Clinical Characteristics of Lupus Erythematosus Panniculitis/Profundus: A Retrospective Review of 61 Patients

Lauren K Rangel; Camila Villa-Ruiz; Kelly Lo; Gabriela Cobos; Kristen Lo Sicco; Ruth Ann Vleugels; Alisa N Femia

doi:10.1001/jamadermatol.2020.2797

Clinical Characteristics of Lupus Erythematosus Panniculitis/Profundus: A Retrospective Review of 61 Patients

JAMA Dermatol. 2020 Nov 1;156(11):1264-1266. doi: 10.1001/jamadermatol.2020.2797.

Authors

Lauren K Rangel¹, Camila Villa-Ruiz^{2

3}, Kelly Lo³, Gabriela Cobos³, Kristen Lo Sicco¹, Ruth Ann Vleugels³, Alisa N Femia¹

Affiliations

¹ The Ronald O. Perelman Department of Dermatology, New York University Langone Medical Center, New York, New York.
² Ponce Health Sciences University, Ponce, Puerto Rico.
³ Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Abstract

This case series characterizes the initial presentation and treatment of lupus erythematosus panniculitis/profundus and its association with systemic lupus erythematosus and discoid lupus erythematosus.

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Antirheumatic Agents / therapeutic use*
Child
Child, Preschool
Comorbidity
Delayed Diagnosis / statistics & numerical data
Female
Humans
Immunosuppressive Agents / therapeutic use*
Lupus Erythematosus, Systemic / drug therapy
Lupus Erythematosus, Systemic / epidemiology*
Lupus Erythematosus, Systemic / immunology
Male
Middle Aged
Panniculitis, Lupus Erythematosus / diagnosis*
Panniculitis, Lupus Erythematosus / drug therapy
Panniculitis, Lupus Erythematosus / epidemiology
Panniculitis, Lupus Erythematosus / immunology
Retrospective Studies
Young Adult

Substances

Antirheumatic Agents
Immunosuppressive Agents